UKCA and MHRA regulatory support for medical devices including transition from CE marking.
UKCA & MHRA Regulatory Support
We support manufacturers navigating UKCA marking and MHRA requirements, including CE to UKCA transition strategies.
Our approach integrates technical documentation alignment, classification strategy, and lifecycle regulatory management — ensuring structured compliance under the UK Medical Devices Regulations 2002 (as amended).
Regulatory Pathway & Classification
- UK device classification (Class I, IIa, IIb, III)
- IVD classification alignment
- CE to UKCA transition planning
- UK Responsible Person (UKRP) strategy
- Conformity assessment route determination
Technical Documentation Alignment
- Technical file & design dossier review
- Clinical evaluation alignment (UK expectations)
- PMS & Vigilance framework alignment
- Risk management documentation (ISO 14971)
- Post-market surveillance & UK vigilance reporting strategy
Lifecycle Compliance & Transition Strategy
- CE to UKCA migration roadmap
- Regulatory change management
- Post-approval variation support
- Vigilance reporting architecture
- Ongoing compliance monitoring
UKCA & MHRA Registration
Bioexcel supports manufacturers navigating the UK regulatory framework, including UKCA marking, CE transition strategy, and MHRA registration requirements.
- UKCA marking roadmap
- MHRA device registration (DORS)
- UK Responsible Person documentation
- Declaration of Conformity alignment
- Labeling & UDI compliance (UK requirements)
Regulatory Framework Alignment
Our UK submissions align with:
- UK Medical Devices Regulations 2002 (as amended)
- MHRA guidance documents
- UKCA conformity assessment requirements
- UK vigilance reporting obligations
- PMS & post-market monitoring expectations
We structure documentation anticipating MHRA review expectations and market surveillance scrutiny.
Beyond UK Registration Support
We design UK regulatory strategies with:
- Structured CE-to-UKCA transition architecture
- Clear documentation defensibility
- UKRP integration planning
- Regulatory continuity risk mitigation
- Harmonized EU–UK lifecycle compliance
Our objective: ensure seamless UK market access without regulatory disruption.
Frequently Asked Questions (FAQ)
Regulatory
UKCA & MHRA Medical Device Regulatory Support
UKCA and MHRA regulatory support for medical devices including transition from CE marking.